nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0506	0.208	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0342	0.141	CbGpPWpGaD
Azacitidine—DNMT3A—DNA methylation—DNMT3L—testicular cancer	0.0298	0.123	CbGpPWpGaD
Azacitidine—DNMT3A—embryo—testicular cancer	0.0251	0.138	CbGeAlD
Azacitidine—DNMT3A—seminal vesicle—testicular cancer	0.0235	0.13	CbGeAlD
Azacitidine—DNMT1—DNA methylation—DNMT3L—testicular cancer	0.0202	0.0828	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.0174	0.0713	CbGpPWpGaD
Azacitidine—DNMT3A—gonad—testicular cancer	0.017	0.0938	CbGeAlD
Azacitidine—DNMT1—embryo—testicular cancer	0.0152	0.0836	CbGeAlD
Azacitidine—DNMT1—seminal vesicle—testicular cancer	0.0142	0.0785	CbGeAlD
Azacitidine—DNMT3A—female gonad—testicular cancer	0.0138	0.0762	CbGeAlD
Azacitidine—DNMT3A—testis—testicular cancer	0.0123	0.0676	CbGeAlD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.0117	0.0482	CbGpPWpGaD
Azacitidine—CDA—testis—testicular cancer	0.0116	0.0639	CbGeAlD
Azacitidine—DNMT3A—DNA methylation—H2AFZ—testicular cancer	0.0104	0.0429	CbGpPWpGaD
Azacitidine—DNMT1—gonad—testicular cancer	0.0103	0.0567	CbGeAlD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—H2AFZ—testicular cancer	0.00948	0.0389	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—H2AFZ—testicular cancer	0.00897	0.0368	CbGpPWpGaD
Azacitidine—DNMT3A—lymph node—testicular cancer	0.00889	0.049	CbGeAlD
Azacitidine—CDA—lymph node—testicular cancer	0.0084	0.0463	CbGeAlD
Azacitidine—DNMT1—female gonad—testicular cancer	0.00836	0.0461	CbGeAlD
Azacitidine—DNMT1—testis—testicular cancer	0.00742	0.0409	CbGeAlD
Azacitidine—DNMT1—DNA methylation—H2AFZ—testicular cancer	0.00705	0.029	CbGpPWpGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—H2AFZ—testicular cancer	0.0064	0.0263	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.00608	0.025	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—H2AFZ—testicular cancer	0.00538	0.0221	CbGpPWpGaD
Azacitidine—DNMT1—lymph node—testicular cancer	0.00538	0.0296	CbGeAlD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—H2AFZ—testicular cancer	0.00474	0.0195	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—H2AFZ—testicular cancer	0.00463	0.019	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.0041	0.0169	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.00383	0.0157	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—DNMT3L—testicular cancer	0.0029	0.0119	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—DNMT3L—testicular cancer	0.00196	0.00805	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HPGDS—testicular cancer	0.00104	0.00426	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—H2AFZ—testicular cancer	0.00102	0.00417	CbGpPWpGaD
Azacitidine—CDA—Metabolism—STK11—testicular cancer	0.000752	0.00309	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—H2AFZ—testicular cancer	0.000686	0.00282	CbGpPWpGaD
Azacitidine—Neutropenia—Doxorubicin—testicular cancer	0.000335	0.000583	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000333	0.00058	CcSEcCtD
Azacitidine—Haemoglobin—Methotrexate—testicular cancer	0.000333	0.000579	CcSEcCtD
Azacitidine—Haemorrhage—Methotrexate—testicular cancer	0.000332	0.000576	CcSEcCtD
Azacitidine—Haematuria—Epirubicin—testicular cancer	0.00033	0.000573	CcSEcCtD
Azacitidine—Dizziness—Ifosfamide—testicular cancer	0.000329	0.000572	CcSEcCtD
Azacitidine—Pharyngitis—Methotrexate—testicular cancer	0.000329	0.000572	CcSEcCtD
Azacitidine—Urinary tract disorder—Methotrexate—testicular cancer	0.000327	0.000569	CcSEcCtD
Azacitidine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000327	0.000568	CcSEcCtD
Azacitidine—Epistaxis—Epirubicin—testicular cancer	0.000326	0.000567	CcSEcCtD
Azacitidine—Urethral disorder—Methotrexate—testicular cancer	0.000325	0.000565	CcSEcCtD
Azacitidine—Weight decreased—Doxorubicin—testicular cancer	0.000324	0.000564	CcSEcCtD
Azacitidine—Sinusitis—Epirubicin—testicular cancer	0.000324	0.000564	CcSEcCtD
Azacitidine—Feeling abnormal—Etoposide—testicular cancer	0.000324	0.000563	CcSEcCtD
Azacitidine—Nausea—Dactinomycin—testicular cancer	0.000323	0.000561	CcSEcCtD
Azacitidine—Agranulocytosis—Epirubicin—testicular cancer	0.000323	0.000561	CcSEcCtD
Azacitidine—Pneumonia—Doxorubicin—testicular cancer	0.000322	0.000559	CcSEcCtD
Azacitidine—Gastrointestinal pain—Etoposide—testicular cancer	0.000322	0.000559	CcSEcCtD
Azacitidine—Infestation NOS—Doxorubicin—testicular cancer	0.00032	0.000556	CcSEcCtD
Azacitidine—Infestation—Doxorubicin—testicular cancer	0.00032	0.000556	CcSEcCtD
Azacitidine—Vomiting—Ifosfamide—testicular cancer	0.000317	0.00055	CcSEcCtD
Azacitidine—Hypersensitivity—Cisplatin—testicular cancer	0.000316	0.00055	CcSEcCtD
Azacitidine—Renal failure—Doxorubicin—testicular cancer	0.000314	0.000547	CcSEcCtD
Azacitidine—Rash—Ifosfamide—testicular cancer	0.000314	0.000546	CcSEcCtD
Azacitidine—Dermatitis—Ifosfamide—testicular cancer	0.000314	0.000545	CcSEcCtD
Azacitidine—Urticaria—Etoposide—testicular cancer	0.000312	0.000543	CcSEcCtD
Azacitidine—Haemoglobin—Epirubicin—testicular cancer	0.000312	0.000542	CcSEcCtD
Azacitidine—Stomatitis—Doxorubicin—testicular cancer	0.000312	0.000542	CcSEcCtD
Azacitidine—Rhinitis—Epirubicin—testicular cancer	0.000311	0.000541	CcSEcCtD
Azacitidine—Abdominal pain—Etoposide—testicular cancer	0.000311	0.00054	CcSEcCtD
Azacitidine—Body temperature increased—Etoposide—testicular cancer	0.000311	0.00054	CcSEcCtD
Azacitidine—Urinary tract infection—Doxorubicin—testicular cancer	0.000311	0.00054	CcSEcCtD
Azacitidine—Haemorrhage—Epirubicin—testicular cancer	0.00031	0.000539	CcSEcCtD
Azacitidine—Eye disorder—Methotrexate—testicular cancer	0.00031	0.000539	CcSEcCtD
Azacitidine—Hypoaesthesia—Epirubicin—testicular cancer	0.000309	0.000537	CcSEcCtD
Azacitidine—Asthenia—Cisplatin—testicular cancer	0.000308	0.000535	CcSEcCtD
Azacitidine—Pharyngitis—Epirubicin—testicular cancer	0.000308	0.000535	CcSEcCtD
Azacitidine—Cardiac disorder—Methotrexate—testicular cancer	0.000308	0.000535	CcSEcCtD
Azacitidine—Urinary tract disorder—Epirubicin—testicular cancer	0.000306	0.000533	CcSEcCtD
Azacitidine—Oedema peripheral—Epirubicin—testicular cancer	0.000306	0.000531	CcSEcCtD
Azacitidine—Haematuria—Doxorubicin—testicular cancer	0.000305	0.00053	CcSEcCtD
Azacitidine—Connective tissue disorder—Epirubicin—testicular cancer	0.000305	0.00053	CcSEcCtD
Azacitidine—Urethral disorder—Epirubicin—testicular cancer	0.000304	0.000529	CcSEcCtD
Azacitidine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000302	0.000526	CcSEcCtD
Azacitidine—Epistaxis—Doxorubicin—testicular cancer	0.000302	0.000524	CcSEcCtD
Azacitidine—Angiopathy—Methotrexate—testicular cancer	0.000301	0.000523	CcSEcCtD
Azacitidine—Sinusitis—Doxorubicin—testicular cancer	0.0003	0.000522	CcSEcCtD
Azacitidine—Immune system disorder—Methotrexate—testicular cancer	0.000299	0.000521	CcSEcCtD
Azacitidine—Mediastinal disorder—Methotrexate—testicular cancer	0.000299	0.00052	CcSEcCtD
Azacitidine—Agranulocytosis—Doxorubicin—testicular cancer	0.000298	0.000519	CcSEcCtD
Azacitidine—Chills—Methotrexate—testicular cancer	0.000297	0.000517	CcSEcCtD
Azacitidine—Nausea—Ifosfamide—testicular cancer	0.000296	0.000514	CcSEcCtD
Azacitidine—Diarrhoea—Cisplatin—testicular cancer	0.000294	0.000511	CcSEcCtD
Azacitidine—Alopecia—Methotrexate—testicular cancer	0.000293	0.000509	CcSEcCtD
Azacitidine—Mental disorder—Methotrexate—testicular cancer	0.00029	0.000505	CcSEcCtD
Azacitidine—Eye disorder—Epirubicin—testicular cancer	0.00029	0.000504	CcSEcCtD
Azacitidine—Hypersensitivity—Etoposide—testicular cancer	0.00029	0.000504	CcSEcCtD
Azacitidine—Erythema—Methotrexate—testicular cancer	0.000289	0.000502	CcSEcCtD
Azacitidine—Malnutrition—Methotrexate—testicular cancer	0.000289	0.000502	CcSEcCtD
Azacitidine—Haemoglobin—Doxorubicin—testicular cancer	0.000289	0.000502	CcSEcCtD
Azacitidine—Cardiac disorder—Epirubicin—testicular cancer	0.000288	0.000501	CcSEcCtD
Azacitidine—Rhinitis—Doxorubicin—testicular cancer	0.000288	0.0005	CcSEcCtD
Azacitidine—Haemorrhage—Doxorubicin—testicular cancer	0.000287	0.000499	CcSEcCtD
Azacitidine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000286	0.000497	CcSEcCtD
Azacitidine—Pharyngitis—Doxorubicin—testicular cancer	0.000285	0.000495	CcSEcCtD
Azacitidine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000284	0.000493	CcSEcCtD
Azacitidine—Oedema peripheral—Doxorubicin—testicular cancer	0.000283	0.000492	CcSEcCtD
Azacitidine—Asthenia—Etoposide—testicular cancer	0.000282	0.000491	CcSEcCtD
Azacitidine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000282	0.00049	CcSEcCtD
Azacitidine—Angiopathy—Epirubicin—testicular cancer	0.000281	0.000489	CcSEcCtD
Azacitidine—Urethral disorder—Doxorubicin—testicular cancer	0.000281	0.000489	CcSEcCtD
Azacitidine—Immune system disorder—Epirubicin—testicular cancer	0.00028	0.000487	CcSEcCtD
Azacitidine—Mediastinal disorder—Epirubicin—testicular cancer	0.00028	0.000486	CcSEcCtD
Azacitidine—Back pain—Methotrexate—testicular cancer	0.000279	0.000485	CcSEcCtD
Azacitidine—Chills—Epirubicin—testicular cancer	0.000278	0.000484	CcSEcCtD
Azacitidine—Pruritus—Etoposide—testicular cancer	0.000278	0.000484	CcSEcCtD
Azacitidine—Alopecia—Epirubicin—testicular cancer	0.000274	0.000477	CcSEcCtD
Azacitidine—Vomiting—Cisplatin—testicular cancer	0.000273	0.000475	CcSEcCtD
Azacitidine—Mental disorder—Epirubicin—testicular cancer	0.000272	0.000473	CcSEcCtD
Azacitidine—Rash—Cisplatin—testicular cancer	0.000271	0.000471	CcSEcCtD
Azacitidine—Dermatitis—Cisplatin—testicular cancer	0.00027	0.00047	CcSEcCtD
Azacitidine—Malnutrition—Epirubicin—testicular cancer	0.00027	0.00047	CcSEcCtD
Azacitidine—Erythema—Epirubicin—testicular cancer	0.00027	0.00047	CcSEcCtD
Azacitidine—Diarrhoea—Etoposide—testicular cancer	0.000269	0.000468	CcSEcCtD
Azacitidine—Eye disorder—Doxorubicin—testicular cancer	0.000268	0.000466	CcSEcCtD
Azacitidine—Ill-defined disorder—Methotrexate—testicular cancer	0.000268	0.000466	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—testicular cancer	0.000267	0.000464	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—testicular cancer	0.000266	0.000463	CcSEcCtD
Azacitidine—Back pain—Epirubicin—testicular cancer	0.000261	0.000454	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—testicular cancer	0.00026	0.000453	CcSEcCtD
Azacitidine—Malaise—Methotrexate—testicular cancer	0.00026	0.000453	CcSEcCtD
Azacitidine—Dizziness—Etoposide—testicular cancer	0.00026	0.000452	CcSEcCtD
Azacitidine—Muscle spasms—Epirubicin—testicular cancer	0.00026	0.000451	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—testicular cancer	0.000259	0.000451	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000259	0.00045	CcSEcCtD
Azacitidine—Leukopenia—Methotrexate—testicular cancer	0.000258	0.000449	CcSEcCtD
Azacitidine—Chills—Doxorubicin—testicular cancer	0.000258	0.000448	CcSEcCtD
Azacitidine—Nausea—Cisplatin—testicular cancer	0.000255	0.000443	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—testicular cancer	0.000254	0.000441	CcSEcCtD
Azacitidine—Cough—Methotrexate—testicular cancer	0.000252	0.000438	CcSEcCtD
Azacitidine—Mental disorder—Doxorubicin—testicular cancer	0.000252	0.000437	CcSEcCtD
Azacitidine—Ill-defined disorder—Epirubicin—testicular cancer	0.000251	0.000436	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—testicular cancer	0.00025	0.000435	CcSEcCtD
Azacitidine—Vomiting—Etoposide—testicular cancer	0.00025	0.000435	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—testicular cancer	0.00025	0.000435	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—testicular cancer	0.00025	0.000435	CcSEcCtD
Azacitidine—Anaemia—Epirubicin—testicular cancer	0.00025	0.000434	CcSEcCtD
Azacitidine—Rash—Etoposide—testicular cancer	0.000248	0.000431	CcSEcCtD
Azacitidine—Dermatitis—Etoposide—testicular cancer	0.000248	0.000431	CcSEcCtD
Azacitidine—Headache—Etoposide—testicular cancer	0.000246	0.000428	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—testicular cancer	0.000246	0.000427	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—testicular cancer	0.000246	0.000427	CcSEcCtD
Azacitidine—Chest pain—Methotrexate—testicular cancer	0.000246	0.000427	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000244	0.000424	CcSEcCtD
Azacitidine—Malaise—Epirubicin—testicular cancer	0.000244	0.000423	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—testicular cancer	0.000243	0.000422	CcSEcCtD
Azacitidine—Syncope—Epirubicin—testicular cancer	0.000242	0.000421	CcSEcCtD
Azacitidine—Leukopenia—Epirubicin—testicular cancer	0.000242	0.00042	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—testicular cancer	0.000242	0.00042	CcSEcCtD
Azacitidine—Muscle spasms—Doxorubicin—testicular cancer	0.00024	0.000418	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—testicular cancer	0.000237	0.000413	CcSEcCtD
Azacitidine—Loss of consciousness—Epirubicin—testicular cancer	0.000237	0.000413	CcSEcCtD
Azacitidine—Cough—Epirubicin—testicular cancer	0.000236	0.00041	CcSEcCtD
Azacitidine—Anaphylactic shock—Methotrexate—testicular cancer	0.000236	0.00041	CcSEcCtD
Azacitidine—Convulsion—Epirubicin—testicular cancer	0.000234	0.000407	CcSEcCtD
Azacitidine—Infection—Methotrexate—testicular cancer	0.000234	0.000407	CcSEcCtD
Azacitidine—Nausea—Etoposide—testicular cancer	0.000234	0.000406	CcSEcCtD
Azacitidine—Hypertension—Epirubicin—testicular cancer	0.000233	0.000405	CcSEcCtD
Azacitidine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000232	0.000403	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—testicular cancer	0.000231	0.000402	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—testicular cancer	0.000231	0.000402	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000231	0.000401	CcSEcCtD
Azacitidine—Arthralgia—Epirubicin—testicular cancer	0.00023	0.0004	CcSEcCtD
Azacitidine—Chest pain—Epirubicin—testicular cancer	0.00023	0.0004	CcSEcCtD
Azacitidine—Myalgia—Epirubicin—testicular cancer	0.00023	0.0004	CcSEcCtD
Azacitidine—Anxiety—Epirubicin—testicular cancer	0.000229	0.000398	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—testicular cancer	0.000229	0.000398	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000228	0.000397	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—testicular cancer	0.000228	0.000396	CcSEcCtD
Azacitidine—Discomfort—Epirubicin—testicular cancer	0.000227	0.000395	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—testicular cancer	0.000225	0.000392	CcSEcCtD
Azacitidine—Anorexia—Methotrexate—testicular cancer	0.000225	0.00039	CcSEcCtD
Azacitidine—Syncope—Doxorubicin—testicular cancer	0.000224	0.00039	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—testicular cancer	0.000224	0.000389	CcSEcCtD
Azacitidine—Confusional state—Epirubicin—testicular cancer	0.000222	0.000386	CcSEcCtD
Azacitidine—Anaphylactic shock—Epirubicin—testicular cancer	0.00022	0.000383	CcSEcCtD
Azacitidine—Oedema—Epirubicin—testicular cancer	0.00022	0.000383	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—testicular cancer	0.00022	0.000383	CcSEcCtD
Azacitidine—Loss of consciousness—Doxorubicin—testicular cancer	0.00022	0.000382	CcSEcCtD
Azacitidine—Infection—Epirubicin—testicular cancer	0.000219	0.000381	CcSEcCtD
Azacitidine—Cough—Doxorubicin—testicular cancer	0.000218	0.000379	CcSEcCtD
Azacitidine—Shock—Epirubicin—testicular cancer	0.000217	0.000377	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—testicular cancer	0.000217	0.000376	CcSEcCtD
Azacitidine—Nervous system disorder—Epirubicin—testicular cancer	0.000216	0.000376	CcSEcCtD
Azacitidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000216	0.000375	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—testicular cancer	0.000216	0.000375	CcSEcCtD
Azacitidine—Tachycardia—Epirubicin—testicular cancer	0.000215	0.000374	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000215	0.000373	CcSEcCtD
Azacitidine—Skin disorder—Epirubicin—testicular cancer	0.000214	0.000372	CcSEcCtD
Azacitidine—Hyperhidrosis—Epirubicin—testicular cancer	0.000213	0.00037	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—testicular cancer	0.000213	0.00037	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—testicular cancer	0.000213	0.00037	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—testicular cancer	0.000213	0.00037	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—testicular cancer	0.000213	0.00037	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—testicular cancer	0.000212	0.000369	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000211	0.000367	CcSEcCtD
Azacitidine—Discomfort—Doxorubicin—testicular cancer	0.00021	0.000365	CcSEcCtD
Azacitidine—Anorexia—Epirubicin—testicular cancer	0.00021	0.000365	CcSEcCtD
Azacitidine—Dyspnoea—Methotrexate—testicular cancer	0.00021	0.000365	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—testicular cancer	0.000207	0.00036	CcSEcCtD
Azacitidine—Hypotension—Epirubicin—testicular cancer	0.000206	0.000358	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—testicular cancer	0.000206	0.000358	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—testicular cancer	0.000205	0.000356	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000204	0.000355	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—testicular cancer	0.000204	0.000355	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000203	0.000354	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—testicular cancer	0.000203	0.000353	CcSEcCtD
Azacitidine—Infection—Doxorubicin—testicular cancer	0.000203	0.000352	CcSEcCtD
Azacitidine—Pain—Methotrexate—testicular cancer	0.000201	0.00035	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000201	0.000349	CcSEcCtD
Azacitidine—Shock—Doxorubicin—testicular cancer	0.000201	0.000349	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—testicular cancer	0.0002	0.000348	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—testicular cancer	0.0002	0.000347	CcSEcCtD
Azacitidine—Insomnia—Epirubicin—testicular cancer	0.000199	0.000347	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—testicular cancer	0.000199	0.000346	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—testicular cancer	0.000198	0.000344	CcSEcCtD
Azacitidine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000197	0.000343	CcSEcCtD
Azacitidine—Dyspnoea—Epirubicin—testicular cancer	0.000197	0.000342	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—testicular cancer	0.000194	0.000338	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—testicular cancer	0.000194	0.000337	CcSEcCtD
Azacitidine—Dyspepsia—Epirubicin—testicular cancer	0.000194	0.000337	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000193	0.000335	CcSEcCtD
Azacitidine—Decreased appetite—Epirubicin—testicular cancer	0.000192	0.000333	CcSEcCtD
Azacitidine—Hypotension—Doxorubicin—testicular cancer	0.000191	0.000331	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00019	0.000331	CcSEcCtD
Azacitidine—Fatigue—Epirubicin—testicular cancer	0.00019	0.00033	CcSEcCtD
Azacitidine—Pain—Epirubicin—testicular cancer	0.000188	0.000328	CcSEcCtD
Azacitidine—Constipation—Epirubicin—testicular cancer	0.000188	0.000328	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—testicular cancer	0.000187	0.000325	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—testicular cancer	0.000186	0.000324	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—testicular cancer	0.000186	0.000324	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000186	0.000323	CcSEcCtD
Azacitidine—Insomnia—Doxorubicin—testicular cancer	0.000184	0.000321	CcSEcCtD
Azacitidine—Dyspnoea—Doxorubicin—testicular cancer	0.000182	0.000316	CcSEcCtD
Azacitidine—Feeling abnormal—Epirubicin—testicular cancer	0.000182	0.000316	CcSEcCtD
Azacitidine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00018	0.000313	CcSEcCtD
Azacitidine—Dyspepsia—Doxorubicin—testicular cancer	0.00018	0.000312	CcSEcCtD
Azacitidine—Decreased appetite—Doxorubicin—testicular cancer	0.000177	0.000308	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000176	0.000306	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—testicular cancer	0.000176	0.000306	CcSEcCtD
Azacitidine—Urticaria—Epirubicin—testicular cancer	0.000175	0.000304	CcSEcCtD
Azacitidine—Pain—Doxorubicin—testicular cancer	0.000174	0.000303	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—testicular cancer	0.000174	0.000303	CcSEcCtD
Azacitidine—Abdominal pain—Epirubicin—testicular cancer	0.000174	0.000303	CcSEcCtD
Azacitidine—Body temperature increased—Epirubicin—testicular cancer	0.000174	0.000303	CcSEcCtD
Azacitidine—Hypersensitivity—Methotrexate—testicular cancer	0.000174	0.000302	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—testicular cancer	0.000169	0.000294	CcSEcCtD
Azacitidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000168	0.000292	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000167	0.00029	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—testicular cancer	0.000167	0.00029	CcSEcCtD
Azacitidine—Hypersensitivity—Epirubicin—testicular cancer	0.000162	0.000282	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—testicular cancer	0.000162	0.000282	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—testicular cancer	0.000161	0.00028	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—testicular cancer	0.000161	0.00028	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—testicular cancer	0.000161	0.00028	CcSEcCtD
Azacitidine—Asthenia—Epirubicin—testicular cancer	0.000158	0.000275	CcSEcCtD
Azacitidine—Pruritus—Epirubicin—testicular cancer	0.000156	0.000271	CcSEcCtD
Azacitidine—Dizziness—Methotrexate—testicular cancer	0.000156	0.000271	CcSEcCtD
Azacitidine—Diarrhoea—Epirubicin—testicular cancer	0.000151	0.000262	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—testicular cancer	0.00015	0.000261	CcSEcCtD
Azacitidine—Vomiting—Methotrexate—testicular cancer	0.00015	0.00026	CcSEcCtD
Azacitidine—Rash—Methotrexate—testicular cancer	0.000149	0.000258	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—testicular cancer	0.000148	0.000258	CcSEcCtD
Azacitidine—Headache—Methotrexate—testicular cancer	0.000148	0.000257	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—testicular cancer	0.000146	0.000254	CcSEcCtD
Azacitidine—Dizziness—Epirubicin—testicular cancer	0.000146	0.000253	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—testicular cancer	0.000144	0.000251	CcSEcCtD
Azacitidine—Vomiting—Epirubicin—testicular cancer	0.00014	0.000244	CcSEcCtD
Azacitidine—Nausea—Methotrexate—testicular cancer	0.00014	0.000243	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—testicular cancer	0.00014	0.000243	CcSEcCtD
Azacitidine—Rash—Epirubicin—testicular cancer	0.000139	0.000242	CcSEcCtD
Azacitidine—Dermatitis—Epirubicin—testicular cancer	0.000139	0.000241	CcSEcCtD
Azacitidine—Headache—Epirubicin—testicular cancer	0.000138	0.00024	CcSEcCtD
Azacitidine—Dizziness—Doxorubicin—testicular cancer	0.000135	0.000234	CcSEcCtD
Azacitidine—Nausea—Epirubicin—testicular cancer	0.000131	0.000228	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—testicular cancer	0.00013	0.000225	CcSEcCtD
Azacitidine—Rash—Doxorubicin—testicular cancer	0.000129	0.000224	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—testicular cancer	0.000128	0.000223	CcSEcCtD
Azacitidine—Headache—Doxorubicin—testicular cancer	0.000128	0.000222	CcSEcCtD
Azacitidine—Nausea—Doxorubicin—testicular cancer	0.000121	0.000211	CcSEcCtD
